CMV virus can cause considerable problems after allogeneic transplantation. Dr. Tsiporah Shore was an important contributor to a recent study of brincidofovir for prevention of CMV virus.  The results of this study were presented at ASBMT in Honolulu, Hawaii and received an award for best abstract.

Brincidofovir for Prevention of Cytomegalovirus (CMV) after Allogeneic Hematopoietic Cell Transplantation (HCT) in CMV-Seropositive Patients: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Trial